Ozempic Changing How You Trade? The Hidden Link Between GLP1 Drugs And RiskTaking
Could Ozempic reshape risk appetite in financial markets? Emerging research on GLP-1 drugs like semaglutide suggests they dampen dopamine-driven anticipation in the brain's reward circuitry—potentially muting the thrill-seeking behaviour tied to trading and high-risk investing.
Could Ozempic reshape risk appetite in financial markets? Emerging research on GLP-1 drugs like semaglutide suggests they dampen dopamine-driven anticipation in the brain's reward circuitry—potentially muting the thrill-seeking behaviour tied to trading and high-risk investing.
What's Your Reaction?
